Mind Medicine (MindMed) Inc. announced the appointment of Francois Lilienthal, MD as Chief Commercial Officer. With more than two decades of global biopharmaceutical experience and after serving as a consultant for MindMed over the past six months, Dr. Lilienthal will step into this role to support the advancement of the Company's clinical development programs. Dr. Lilienthal held several global leadership roles at Merck. Dr. Lilienthal served as Executive Director and U.S. Brand Leader at Tibotec.

Dr. Lilienthal has also served as Executive Director and Global Marketing Leader at The Janssen Pharmaceutical Companies of Johnson & Johnson and Director and Global Marketing Leader at Bristol Myers Squibb.